CookDRStillerRLWeaklyJNChakravortiSBrandonBWWelchRM. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg1989; 68: 452–6.
2.
OstergaardDJensenEJensenFSMogensenJ Viby. The duration of action of mivacurium-induced neuromuscular block in patients homozygous for the atypical plasma cholinesterase gene. Anesthesiology1991; 75 (suppl): A774.
3.
BellM.Reversal of mivacurium apnoea with neostigmine [Letter]. Anaesthesia1994; 49: 350.
4.
OstergaardDJensenFSJensenEMogensenJ Vilby. Mivacurium induced neuromuscular blockade (NMB) in patients heterozygous for the atypical gene for plasma cholinesterase. Anesthesiology1989; 71 (suppl): A782.
5.
PetersenRSBaileyPLKalameghanRAshwoodER. Prolonged neuromuscular block after mivacurium. Anesth Analg1993; 76: 194–6.
KalowWLindsayHA. A comparison of optical and manometric methods of the assay of human serum cholinesterase. Can J Biochem Physiol1955; 33: 568–74.
8.
KalowWGenestK.A method for the detection of atypical forms of human serum cholinesterase: Determination of dibucaine numbers. Can J Biochem Physiol1957; 35: 339–46.
9.
HarrisHWhittakerM.Differential inhibition of human serum cholinesterase with fluoride: Recognition of two new phenotypes. Nature1961; 191: 496–8.
10.
LiddellJNewmanGEBrownDF. A pseudocholinesterase variant in human tissues. Nature1963; 198: 1090–1.
11.
WhittakerMBrittenJJ. Differential inhibition of plasma cholinesterase variants using the dibutyrate analogue of pancuronium bromide. Hum Hered1981; 31: 242–7.
12.
RubinsteinHMDietzAAHodgesLKLubranoTCzebotarV.Silent cholinesterase gene: Variations in the properties of serum enzyme in apparent homozygotes. J Clin Invest1970; 49: 479–86.
13.
ScottEMWrightRC. A third type of serum cholinesterase deficiency in Eskimos. Am J Hum Genet1976; 28: 253–6.
